Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stroke
US-12480959-B2 · Nov 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Maastricht Univ Medical Center patents
Maastricht Univ Medical Center holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 1 |
| First publication | May 30, 2019 |
| Latest publication | Nov 25, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Uses of biomarkers for improving immunotherapy
US-2023075965-A1 · Mar 9, 2023 · US
Fatty acid binding protein 3 for the assessment of atrial fibrillation (af)
US-2020116708-A1 · Apr 16, 2020 · US
Circulating esm-1 (endocan) in the assessment of atrial fibrillation and/or stroke
US-2019162737-A1 · May 30, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stroke
US-12480959-B2 · Nov 25, 2025 · US
Uses of biomarkers for improving immunotherapy
US-2023075965-A1 · Mar 9, 2023 · US
Fatty acid binding protein 3 for the assessment of atrial fibrillation (af)
US-2020116708-A1 · Apr 16, 2020 · US
Circulating esm-1 (endocan) in the assessment of atrial fibrillation and/or stroke
US-2019162737-A1 · May 30, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Physics | 4 |
| Chemistry & Metallurgy | 2 |